FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation; Authorizes Guardant360 CDx Assay As Companion Diagnostic For Breast Cancer
https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-breast-cancer-treatment
The FDA approved a new breast cancer medicine called Etcamah for patients with a specific genetic change. This is good news for the company making it, and it shows the medicine works well enough to help sick people right away.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.